Oxford University's COVID-19 Vaccine Candidate Triggers Immune Response Claim Researchers

In a preliminary report published in The Lancet, researchers at the University of Oxford have said that the COVID-19 vaccine candidate ChAdOx1 nCoV-19 appears to be safe and has triggered an immune response.  Of the 1,077 people involved in the trials, 90% developed neutralising antibodies after one dose. There are side-effects to the vaccine with 70% of people developing a fever or a headache.